Motti Farbstein
CIK: 0002116362
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CANF
Can-Fite BioPharma Ltd.
Officer
Discretionary Trading P&L
Holdings
About Farbstein Motti
Farbstein Motti (SEC CIK 0002116362) files insider reports with the SEC as CEO, CFO and COO of Can-Fite BioPharma Ltd. (CANF).
Signal8 holds 2 ownership filings by Farbstein Motti (1 Form 3, 1 Form 4), filed between Mar 18, 2026 and Jun 8, 2026. Those filings report 1 transaction, the latest on Jun 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Farbstein Motti's filings is in RAMAT GAN.
Recent filings by Farbstein Motti
- Jun 4, 2026: Grant or award of CANF derivative securities (Form 4, code A).
Other insiders filing for Can-Fite BioPharma Ltd. (CANF)
- Fishman Pnina, Chief Scientific Officer
- Tamir Ilan, Director
- Regev Guy, Director
- Bornstein Yoseph, Director
- Sartani Abraham, Director
- Fishman Sari, VP Business Development